Showing results (371-380 of 426) with videos related to

Sort By:
Pageof 43
The Canadian Journal of Cardiology|April 14, 2010
The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programsJonathan G Howlett, Robert S McKelvie, Jeannine Costigan, et al.
JACC. Heart Failure|December 31, 2016
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF TrialAndrew P Ambrosy, Lukasz P Cerbin, Paul W Armstrong, et al.
The Canadian Journal of Cardiology|February 14, 2009
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsJonathan G Howlett, Robert S McKelvie, J Malcolm O Arnold, et al.
Scientific Reports|June 24, 2022
Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, CanadaJacob A Udell, Bahar Behrouzi, Atul Sivaswamy, et al.
European Journal of Heart Failure|October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrumJaved Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
The Canadian Journal of Cardiology|January 23, 2008
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesJ Malcom, O Arnold, Jonathan G Howlett, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Lancet (London, England)|December 5, 2016
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trialJohn R Teerlink, G Michael Felker, John J V McMurray, et al.
The American Journal of Cardiology|August 6, 2022
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)Beth A Davison, Koji Takagi, Christopher Edwards, et al.
Pageof 43